A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-26
DOI
10.3389/fmolb.2021.611367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BBB pathophysiology–independent delivery of siRNA in traumatic brain injury
- (2021) Wen Li et al. Science Advances
- Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
- (2020) Yutong Zhou et al. Science Advances
- Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
- (2018) Tian Tian et al. BIOMATERIALS
- A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model
- (2018) George Thom et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy
- (2018) Xing Guo et al. ACS Nano
- Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke
- (2018) Georgios Tsivgoulis et al. NEUROLOGY
- Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke
- (2017) Yuan-Yuan Qin et al. FREE RADICAL BIOLOGY AND MEDICINE
- NADPH Oxidase-Related Pathophysiology in Experimental Models of Stroke
- (2017) Hiroshi Yao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NADPH oxidase in brain injury and neurodegenerative disorders
- (2017) Merry W. Ma et al. Molecular Neurodegeneration
- Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s Disease
- (2017) Christin Helmschrodt et al. Molecular Therapy-Nucleic Acids
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
- (2016) Jinho Park et al. ADVANCED DRUG DELIVERY REVIEWS
- Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases
- (2016) Valerio Chiurchiù et al. Oxidative Medicine and Cellular Longevity
- A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries
- (2016) Aman P. Mann et al. Nature Communications
- Flagellin-induced NADPH oxidase 4 activation is involved in atherosclerosis
- (2016) Jinoh Kim et al. Scientific Reports
- Global neurotrauma research challenges and opportunities
- (2015) Andrés M. Rubiano et al. NATURE
- The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010
- (2015) Harvey A. Whiteford et al. PLoS One
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury
- (2013) Sean J Cooney et al. Journal of Neuroinflammation
- The current and projected economic burden of Parkinson's disease in the United States
- (2013) Stacey L. Kowal et al. MOVEMENT DISORDERS
- Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
- (2013) Kaan E. Biron et al. Scientific Reports
- Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
- (2012) Kim A. Radermacher et al. ANTIOXIDANTS & REDOX SIGNALING
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Treatment of Risk Factors to Prevent Stroke
- (2011) Junya Aoki et al. Neurotherapeutics
- Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
- (2011) Kaan E. Biron et al. PLoS One
- Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
- (2010) Jami Bennett et al. JOURNAL OF NEUROIMMUNOLOGY
- Targeted Delivery of siRNA to Macrophages for Anti-inflammatory Treatment
- (2010) Sang-Soo Kim et al. MOLECULAR THERAPY
- Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration
- (2010) Christoph Kleinschnitz et al. PLOS BIOLOGY
- Lipid-Lowering Drugs in Ischemic Stroke Prevention and Their Influence on Acute Stroke Outcome
- (2009) Blanca Fuentes et al. CEREBROVASCULAR DISEASES
- NOX4 Expression in Human Microglia Leads to Constitutive Generation of Reactive Oxygen Species and to Constitutive IL-6 Expression
- (2009) Bin Li et al. Journal of Innate Immunity
- Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival
- (2009) H. J. Milionis et al. NEUROLOGY
- Triggers, targets and treatments for thrombosis
- (2008) Nigel Mackman NATURE
- The blood–brain barrier is continuously open for several weeks following transient focal cerebral ischemia
- (2008) D. Strbian et al. NEUROSCIENCE
- A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
- (2008) Delara Karkan et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation